Close
To help employees feel a personal connection to global environmental i...
When newly appointing third parties, such as contractors or agents, we co...
Since 2023, ONO has been participating in Access Accelerated, a global pa...
The materiality analysis implemented in FY2021 was conducted using the...
For more details on each type of training, please see below. ...
Environmental Costs (Including Depreciation Costs) (Thousands o...
In fiscal year 2025, ONO PHARMA TAIWAN supported the activities of ...
We have been holding ESG presentation Meeting every year since March 2...
The total volume of our industrial waste in FY2025 was 479.8 tons, a 338....
We recognize our responsibility, as a pharmaceutical company involved in ...
External evaluation of ESG (Environmental, Social and Governance) ...
As social structures evolve due to factors such as technological innovati...
With the aim of increasing children’s interest in science, experiments,...
As part of Deciphera’s Global All Company Meeting in October 2025, em...
Our Materiality Steps in materiality analysis Sustainability Promo...
We set targets for sustainability, including environmental and occupation...
Risk Management Business Continuity Plan (BCP) Major Risks Infor...
In November 2017, we participated in the United Nations Global Compact (U...
Our Approach to Human Rights In all its business activities in and out...
Compliance Promotion System To strengthen our compliance system, we ha...
Support for Disease Prevention, Early Detection and Early Treatment ...
